Opinion · 1 Dec 2025
PerspectivePublished 30 Nov 2024
Targeting PD-1 and CTLA-4: Current Landscape and Future Directions in Immune Checkpoint Inhibition
Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Immune checkpoint inhibitors (ICIs) targeting PD-1 (programmed cell death-1) and CTLA-4 (cytotoxic T-lymphocyte antigen-4) have revolutionized cancer immunotherapy, providing durable responses in various cancers, including melanoma, lung cancer, and renal cell carcinoma. These inhibitors function by blocking immune checkpoints, enhancing T-cell activity against tumor cells. While PD-1 and CTLA-4 inhibitors have shown promising results, challenges remain regarding their efficacy, resistance mechanisms, and patient selection. The combination of PD-1 and CTLA-4 inhibitors has demonstrated synergistic effects, improving therapeutic outcomes compared to monotherapies. However, immunerelated adverse events (irAEs) are a significant concern. Ongoing research is focused on optimizing dosing strategies, exploring biomarkers for patient selection, and addressing mechanisms of resistance. This review discusses the current landscape of PD-1 and CTLA-4 inhibition in cancer therapy, evaluates emerging therapies and combination strategies, and explores future directions for improving outcomes and mitigating side effects.
Keywords
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Immunology: Current Research.
Editorial · 1 Dec 2025
Auto-inflammatory Disorders: Genetic Causes and Targeted Therapies
Editorial · 1 Dec 2025
Host-Parasite Immunological Arena: An Intricate Balance
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunology: Current Research
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Cristae Williams”